[The Efficacy of CDK4/6 Inhibitors as Late Therapy in Patients Treated with Palbociclib and Abemaciclib Two Sequentially]
{{output}}
The combination of endocrine therapy and cyclin-dependent kinase 4/6 inhibitor(CDK4/6 inhibitor)is recommended as primary treatment for hormone receptor-positive HER2-negative metastatic or recurrent breast cancer. In this study, we investigated the efficacy a... ...
